GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunho Biologics Inc (HKSE:02898) » Definitions » ROA %

Sunho Biologics (HKSE:02898) ROA % : -16.35% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Sunho Biologics ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sunho Biologics's annualized Net Income for the quarter that ended in Jun. 2024 was HK$-77.68 Mil. Sunho Biologics's average Total Assets over the quarter that ended in Jun. 2024 was HK$475.02 Mil. Therefore, Sunho Biologics's annualized ROA % for the quarter that ended in Jun. 2024 was -16.35%.

The historical rank and industry rank for Sunho Biologics's ROA % or its related term are showing as below:

HKSE:02898' s ROA % Range Over the Past 10 Years
Min: -73.37   Med: -73.26   Max: -24.57
Current: -24.57

During the past 2 years, Sunho Biologics's highest ROA % was -24.57%. The lowest was -73.37%. And the median was -73.26%.

HKSE:02898's ROA % is ranked better than
59.28% of 1498 companies
in the Biotechnology industry
Industry Median: -34.26 vs HKSE:02898: -24.57

Sunho Biologics ROA % Historical Data

The historical data trend for Sunho Biologics's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunho Biologics ROA % Chart

Sunho Biologics Annual Data
Trend Dec22 Dec23
ROA %
-73.37 -73.15

Sunho Biologics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
ROA % - -169.98 -49.04 -16.35

Competitive Comparison of Sunho Biologics's ROA %

For the Biotechnology subindustry, Sunho Biologics's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunho Biologics's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunho Biologics's ROA % distribution charts can be found below:

* The bar in red indicates where Sunho Biologics's ROA % falls into.


;
;

Sunho Biologics ROA % Calculation

Sunho Biologics's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-145.146/( (79.132+317.688)/ 2 )
=-145.146/198.41
=-73.15 %

Sunho Biologics's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=-77.676/( (317.688+632.347)/ 2 )
=-77.676/475.0175
=-16.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.


Sunho Biologics  (HKSE:02898) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-77.676/475.0175
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-77.676 / 0)*(0 / 475.0175)
=Net Margin %*Asset Turnover
=N/A %*0
=-16.35 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Sunho Biologics ROA % Related Terms

Thank you for viewing the detailed overview of Sunho Biologics's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunho Biologics Business Description

Traded in Other Exchanges
N/A
Address
No. 198 Peninsula Middle Road, Dipu Street, Room 302, Building 3, Anji County, Zhejiang Province, Huzhou, CHN
Sunho Biologics Inc is a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of biologics for the treatment of cancers and autoimmune diseases. It has three Core Products, IAH0968, IAP0971, and IAE0972, all of which are developed in-house. IAH0968 is an antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced monoclonal antibody (mAb), and the company has initiated Phase II clinical trials for biliary tract carcinoma (BTC) and colorectal cancer (CRC). IAP0971 and IAE0972 are both immunocytokines and It has completed Phase I clinical trials for advanced solid tumors including non-small cell lung cancer (NSCLC) and CRC.
Executives
Sunho Fortune Investments Limited 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Zhang Feng 2201 Interest of corporation controlled by you
Sunho Wisdom Investments Limited 2101 Beneficial owner

Sunho Biologics Headlines

No Headlines